Molecular ID and Serology (Antibody) Testing of SARS-CoV2 (COVID19)

Post-test CME/CDE

The Accreditation Council for Continuing Medical Education requires that CME providers document that CME activities increase physician competence or performance or improve patient outcomes. In order to assess whether the recent COVID-19 educational program increased participants' competence in the areas addressed in the Program, AAMS is conducting a post-activity assessment of the Program.

You are asked to complete below quiz on the content of the Educational Expert Series Webinars on Various Aspects of COVID-19.

Your CME/CDE certificate will be emailed to you.

Thank you for your help. The information you provide helps AAMS better address the educational needs of the medical community. We hope the Scientific Program contributed to your professional development.

  • Molecular ID and Serology (Antibody) Testing of SARS-CoV2 (COVID19)

Mike Mkhitar Moradian has received his BS degree in Microbiology and Medical Technology with honors from CSULA, his MS degree in Bioinformatics and PhD in Molecular Genetics from UCLA. Dr. Moradian is a board certified Clinical Laboratory Bioanalyst with the States of California and New York, a Molecular Genetics Scientist from American Board of Bioanalysis, a High Complexity Laboratory Director, and a Clinical Consultant from ABB. He has worked as research scientist and laboratory Director for over a decade developing Genetics assays and setting up laboratories, he is currently the Director of Operations at Kaiser Permanente Regional Molecular Genetic Pathology Laboratory. He is a certified Lean Healthcare expert from Systems Engineering schools of MIT/LMU combined program and a certified laboratory inspector by the College of American Pathologists. He also serves as a senior scientist and consultant for Morava Inc. scientific and technology services leading a research on Familial Mediterranean Fever (FMF). His works on FMF were published in Nature’s Journal of Human Genetics, in Nature’s Journal of Genetics in Medicine, and in the Journal of Molecular Genetic and Genomic Medicine. In 2018 the Yerevan State Medical University (YSMU) granted him an adjunct professorship in the clinical genetics department where he is leading the Armenian Breast Cancer Genetic Project. The first article of this project is under review. During COVID19 pandemic he has set up several molecular diagnostics assays to identify SARS-COV-2 pathogen and has lectured about the virus’s genome evolution for Kaiser Permanente laboratory system and for the YSMU genetics department. He serves as the president of the California Association of Bioanalysts, State’s only laboratory director organization.

  • The Armenian American Medical Society is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
  • The Armenian American Medical Society designates this webinar activity for a maximum of (1) hours AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities. 
  • These credits may also be applied to the CMA Certification in Continuing Medical Education.
  • The Armenian American Medical Society is accredited by the Dental Board of California Registered Provider #5112 to provide continuing dental education. The Armenian American Medical Society designates this webinar activity for maximum of (2) hours of Continuing Dental Education.

This series is complimentary and available to all. CME/CDE credits are available for AAMS members. For all others who would like CME/CDE credits please contact info@aamsc.org.

Webinar Information

Date: August 10, 2020

Time: 07:00 pm